Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE).
[en] Several international guidelines concerning lower extremity arterial disease (LEAD) have been published recently, in particular, by the American Heart Association the European Society of Cardiology/European Society for Vascular Surgery, the European Society for Vascular Medicine and the Society for Vascular Surgery. These guidelines differ in some respects and certain issues are not addressed. The objective of this consensus driven by the French Societies of vascular Medicine and surgery was to analyze the disparities between the different guidelines, as well as certain issues not covered, and develop proposals with regard to these points. The following fields of LEAD have been explored: 1) classifications, 2) clinical evaluation, 3) diagnostic criteria, 4) quantification of arterial stenosis using duplex ultrasound, 5) detection of asymptomatic multisite lesions, 6) screening for LEAD in the context of cardiac disease, 7) medical treatment, 8) supervised exercise therapy, 9) revascularization and revascularization of the internal artery stenosis, 10) management of chronic limb ischemia, 11) longitudinal follow-up, and 12) diet.
Disciplines :
Cardiovascular & respiratory systems
Author, co-author :
Mahé, Guillaume; Vascular Medicine Unit, Rennes University Hospital Centre, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France. Electronic address: maheguillaume@yahoo.fr
Boge, Gudrun; Vascular Medicine Department, Montpellier University Hospital Centre, France
Bura-Rivière, Alessandra; Vascular Medicine Department, Toulouse University Hospital Centre, Rangueil Hospital, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Chakfé, Nabil; Vascular Surgery and Kidney Transplantation Department, Strasbourg University Hospital Centre, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Constans, Joël; Vascular Medicine Department, Bordeaux University Hospital Centre, Saint André Hospital, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Goueffic, Yann; Vascular Surgery Department, Saint-Joseph Paris Hospital Group, Paris, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Lacroix, Philippe; Vascular Medicine Department, Limoges University Hospital Centre, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Le Hello, Claire; Vascular Medicine Department, Saint-Etienne University Hospital, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Pernod, Gilles; Vascular Medicine Department, Grenoble University Hospital Centre, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Perez-Martin, Antonia; Vascular Investigation and Vascular Medicine Department, Nimes University Hospital Centre, France, FCRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) PeripherAL Artery DIsease Network (PALADIN), France
Picquet, Jean; Vascular and Thoracic Surgery Department, Angers University Hospital Centre, France
Sprynger, Muriel ; Université de Liège - ULiège > Département des sciences cliniques
Disparities Between International Guidelines (AHA/ESC/ESVS/ESVM/SVS) Concerning Lower Extremity Arterial Disease: Consensus of the French Society of Vascular Medicine (SFMV) and the French Society for Vascular and Endovascular Surgery (SCVE).
Gerhard-Herman, M.D., Gornik, H.L., Barrett, C., et al. 2016 AHA/ACC guideline on the management of patients with lower extremity peripheral artery disease: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. Circulation 135 (2017), e726–e779.
Aboyans, V., Ricco, J.B., Bartelink, M.E.L., et al. Editor's choice - 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS). Eur J Vasc Endovasc Surg 55 (2018), 305–368.
Frank, U., Nikol, S., Belch, J., et al. Guideline on peripheral arterial disease. Vasa 48:Suppl 102 (2019), 1–79.
Society for Vascular Surgery Lower Extremity Guidelines Writing G Conte, M.S., Pomposelli, F.B., Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: management of asymptomatic disease and claudication. J Vasc Surg 61:3 Suppl (2015), 2S–41S.
Mach, F., Baigent, C., Catapano, A.L., et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2019.
Cosentino, F., Grant, P.J., Aboyans, V., et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J 41 (2020), 255–323.
Mahe, G., Jaquinandi, V., [Diagnosis of lower limb peripheral artery disease]. Presse Med 47 (2018), 47–55.
Clark, C.E., Taylor, R.S., Shore, A.C., et al. Association of a difference in systolic blood pressure between arms with vascular disease and mortality: a systematic review and meta-analysis. Lancet 379 (2012), 905–914.
Winsor, T., Influence of arterial disease on the systolic blood pressure gradients of the extremity. Am J Med Sci 220 (1950), 117–126.
Aboyans, V., Criqui, M.H., Abraham, P., et al. Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association. Circulation 126 (2012), 2890–2909.
Baste IB, C., Constans, J., Conri, C., Validation de la mesure de l'index de pression systolique (IPS) selon deux méthodes: Doppler pulsé et Stéthoflux. J Mal Vasc, 33, 2008, 91.
Gestin, S., Delluc, A., Saliou, A.H., et al. [Ankle brachial pressure index (ABPI): color-Doppler versus ultrasound Doppler correlation study in 98 patients after analysis of interobserver reproducibility]. J Mal Vasc 37 (2012), 186–194.
Gardner, A.W., Montgomery, P.S., Comparison of three blood pressure methods used for determining ankle/brachial index in patients with intermittent claudication. Angiology 49 (1998), 723–728.
Stivalet, O., Paisant, A., Belabbas, D., et al. Exercise testing criteria to diagnose lower extremity peripheral artery disease assessed by computed-tomography angiography. PLoS One, 14, 2019, e0219082.
Aboyans, V., Lacroix, P., Doucet, S., et al. Diagnosis of peripheral arterial disease in general practice: can the ankle-brachial index be measured either by pulse palpation or an automatic blood pressure device?. Int J Clin Pract 62 (2008), 1001–1007.
Verberk, W.J., Kollias, A., Stergiou, G.S., Automated oscillometric determination of the ankle-brachial index: a systematic review and meta-analysis. Hypertens Res 35 (2012), 883–891.
Hamel, J.F., Tanguy, M., Foucaud, D., et al. [Comparison of the automated oscillometric method with Doppler ultrasound method to access the Ankle-Brachial Pressure Index (ABPI)]. J Mal Vasc 35 (2010), 169–174.
Paul, E., Jaquinandi, V., Larralde, A., et al. [Contribution of the maximal exercise test to diagnosis the vascular origin of leg pain in athletes]. J Med Vasc 43 (2018), 379–383.
Cosentino, F., Grant, P.J., Aboyans, V., et al. 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD. Eur Heart J, 2019.
Le Bivic, L., Magne, J., Guy-Moyat, B., et al. The intrinsic prognostic value of the ankle-brachial index is independent from its mode of calculation. Vasc Med 24 (2019), 23–31.
Espinola-Klein, C., Rupprecht, H.J., Bickel, C., et al. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation 118 (2008), 961–967.
Lindholt, J.S., Sogaard, R., Population screening and intervention for vascular disease in Danish men (VIVA): a randomised controlled trial. Lancet 390 (2017), 2256–2265.
Hirsch, A.T., Haskal, Z.J., Hertzer, N.R., et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American association for vascular surgery/society for vascular surgery, society for cardiovascular angiography and interventions, society for vascular medicine and biology, society of interventional radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American association of cardiovascular and pulmonary rehabilitation; national heart, lung, and blood institute; society for vascular nursing; TransAtlantic inter-society consensus; and vascular disease foundation. Circulation 113 (2006), e463–e654.
Stivalet, O., Laneelle, D., Omarjee, L., et al. Post-exercise criteria to diagnose lower extremity peripheral artery disease: which one should I use in my practice?. Vasc Med 24 (2019), 76–77.
Ouriel, K., McDonnell, A.E., Metz, C.E., et al. Critical evaluation of stress testing in the diagnosis of peripheral vascular disease. Surgery 91 (1982), 686–693.
Laing, S., Greenhalgh, R.M., The detection and progression of asymptomatic peripheral arterial disease. Br J Surg 70 (1983), 628–630.
Mahe, G., Pollak, A.W., Liedl, D.A., et al. Discordant diagnosis of lower extremity peripheral artery disease using American heart association postexercise guidelines. Medicine (Baltimore), 94, 2015, e1277.
Aday, A.W., Kinlay, S., Gerhard-Herman, M.D., Comparison of different exercise ankle pressure indices in the diagnosis of peripheral artery disease. Vasc Med, 2018 1358863X18781723.
Carter, S.A., Lezack, J.D., Digital systolic pressures in the lower limb in arterial disease. Circulation 43 (1971), 905–914.
Sawka, A.M., Carter, S.A., Effect of temperature on digital systolic pressures in lower limb in arterial disease. Circulation 85 (1992), 1097–1101.
Perez-Martin, A., Meyer, G., Demattei, C., et al. Validation of a fully automatic photoplethysmographic device for toe blood pressure measurement. Eur J Vasc Endovasc Surg 40 (2010), 515–520.
Watanabe, Y., Masaki, H., Kojima, K., et al. Toe-brachial index in the second toe: substitutability to toe-brachial index in the great toe and ankle-brachial index. Ann Vasc Dis 9 (2016), 300–306.
Tehan, P.E., Santos, D., Chuter, V.H., A systematic review of the sensitivity and specificity of the toe-brachial index for detecting peripheral artery disease. Vasc Med 21 (2016), 382–389.
Hoyer, C., Sandermann, J., Petersen, L.J., The toe-brachial index in the diagnosis of peripheral arterial disease. J Vasc Surg 58 (2013), 231–238.
Norgren, L., Hiatt, W.R., Dormandy, J.A., et al. Inter-Society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45:Suppl (2007), S5–S67.
Criqui, M.H., Vargas, V., Denenberg, J.O., et al. Ethnicity and peripheral arterial disease: the san Diego population study. Circulation 112 (2005), 2703–2707.
Kim, E.S., Scissons, A.M., Dawson, R., et al. Interpretation of peripheral arterial and venous Doppler waveforms: A Consensus Statement from the Society for Vascular Medicine and Society for Vascular. Ultrasound Vasc Med, 2020.
Azzopardi, Y.M., Gatt, A., Chockalingam, N., et al. Agreement of clinical tests for the diagnosis of peripheral arterial disease. Prim Care Diabetes 13 (2019), 82–86.
Scissons, R.P., Characterizing triphasic, biphasic, and monophasic Doppler WaveformsShould a simple task Be so difficult?. J Diagnost Med Sonogr 24 (2008), 269–276.
Omarjee, L., Stivalet, O., Hoffmann, C., et al. Heterogeneity of Doppler waveform description is decreased with the use of a dedicated classification. Vasa 47 (2018), 471–474.
Heiss, H.W., Investigation of vascular disorders. Cardiology, C., (eds.) AN Nicolaides and JST Yao. Churchill Livingstone, 1981.
Wen, C., Gao, M., Fu, Y., et al. A high variability of arterial Doppler waveform descriptions exists in China. Vasc Med, 2020 1358863X20903808.
Mahe, G., Boulon, C., Desormais, I., et al. [College of the French vascular medicine Teachers (CEMV) statement: arterial Doppler waveforms analysis (simplified saint-bonnet classification)]. J Med Vasc 43 (2018), 255–261.
Mahe, G., Boulon, C., Desormais, I., et al. Statement for Doppler waveforms analysis. Vasa 46 (2017), 337–345.
Maufus, M., Sevestre-Pietri, M.A., Sessa, C., et al. Critical limb ischemia and the response to bone marrow-derived cell therapy according to tcPO2 measurement. Vasa 46 (2017), 23–28.
Sarin, S., Shami, S., Shields, D.A., et al. Selection of amputation level: a review. Eur J Vasc Surg 5 (1991), 611–620.
Wang, Z., Hasan, R., Firwana, B., et al. A systematic review and meta-analysis of tests to predict wound healing in diabetic foot. J Vasc Surg 63:2 Suppl (2016), 29S–36S.
Yamada, T., Ohta, T., Ishibashi, H., et al. Clinical reliability and utility of skin perfusion pressure measurement in ischemic limbs–comparison with other noninvasive diagnostic methods. J Vasc Surg 47 (2008), 318–323.
Constans, J., Bura-Riviere, A., Visona, A., et al. Urgent need to clarify the definition of chronic critical limb ischemia - a position paper from the European Society for Vascular Medicine. Vasa 48 (2019), 223–227.
Hauser, C.J., Shoemaker, W.C., Use of a transcutaneous PO2 regional perfusion index to quantify tissue perfusion in peripheral vascular disease. Ann Surg 197 (1983), 337–343.
Grard, C., Desmytterre, J., Vinckier, L., et al. [Value of transcutaneous staged dynamic oximetry of stage II arteritis of the leg]. Arch Mal Coeur Vaiss 83 (1990), 51–57.
Abraham, P., Picquet, J., Vielle, B., et al. Transcutaneous oxygen pressure measurements on the buttocks during exercise to detect proximal arterial ischemia: comparison with arteriography. Circulation 107 (2003), 1896–1900.
Bouye, P., Picquet, J., Jaquinandi, V., et al. Reproducibility of proximal and distal transcutaneous oxygen pressure measurements during exercise in stage 2 arterial claudication. Int Angiol 23 (2004), 114–121.
Poulin, A., Guilcher, A., Omarjee, L., et al. Validation of a software to perform exercise oximetry to diagnose arterial stenosis of the lower limbs. Atherosclerosis 278 (2018), 325–327.
Koch, C., Chauve, E., Chaudru, S., et al. Exercise transcutaneous oxygen pressure measurement has good sensitivity and specificity to detect lower extremity arterial stenosis assessed by computed tomography angiography. Medicine (Baltimore), 95, 2016, e4522.
Mahe, G., Kaladji, A., Le Faucheur, A., et al. Internal iliac artery stenosis: diagnosis and how to manage it in 2015. Front Cardiovasc Med, 2, 2015, 33.
Gernigon, M., Marchand, J., Ouedraogo, N., et al. Proximal ischemia is a frequent cause of exercise-induced pain in patients with a normal ankle to brachial index at rest. Pain Physician 16 (2013), 57–64.
Mahe, G., Kalra, M., Abraham, P., et al. Application of exercise transcutaneous oxygen pressure measurements for detection of proximal lower extremity arterial disease: a case report. Vasc Med 20 (2015), 251–255.
Mahe, G., Catillon, F., Tollenaere, Q., et al. Confirmation of discrepancies between exercise oximetry and American Heart Association post-exercise criteria to diagnose peripheral artery disease in patients with normal ankle-brachial index at rest. Pflugers Arch 472 (2020), 321–322.
Abraham, P., Hersant, J., Ramondou, P., et al. Comparison of exercise oximetry and ankle pressure measurements for patients with intermittent claudication: an observational study of 433 patients. Pflugers Arch 472 (2020), 293–301.
Mahe, G., Catillon, F., Tollenaere, Q., et al. Discordance of peripheral artery disease diagnosis using exercise transcutaneous oxygen pressure measurement and post-exercise ankle-brachial index. Sci Rep, 10, 2020, 7419.
Galland, R.B., Simmons, M.J., Torrie, E.P., Prevalence of abdominal aortic aneurysm in patients with occlusive peripheral vascular disease. Br J Surg 78 (1991), 1259–1260.
Barba, A., Estallo, L., Rodriguez, L., et al. Detection of abdominal aortic aneurysm in patients with peripheral artery disease. Eur J Vasc Endovasc Surg 30 (2005), 504–508.
Giugliano, G., Laurenzano, E., Rengo, C., et al. Abdominal aortic aneurysm in patients affected by intermittent claudication: prevalence and clinical predictors. BMC Surg, 12(Suppl 1), 2012, S17.
de Vries, S.O., Hunink, M.G., Polak, J.F., Summary receiver operating characteristic curves as a technique for meta-analysis of the diagnostic performance of duplex ultrasonography in peripheral arterial disease. Acad Radiol 3 (1996), 361–369.
Collins, R., Burch, J., Cranny, G., et al. Duplex ultrasonography, magnetic resonance angiography, and computed tomography angiography for diagnosis and assessment of symptomatic, lower limb peripheral arterial disease: systematic review. BMJ, 334, 2007, 1257.
Michelet, P.R., Chopard, C.S., Martin, P.Y., et al. [Nephrogenic systemic fibrosis: another problem for patients with chronic renal failure]. Rev Med Suisse 4 (2008), 576–578.
Frans, F.A., Zagers, M.B., Jens, S., et al. The relationship of walking distances estimated by the patient, on the corridor and on a treadmill, and the Walking Impairment Questionnaire in intermittent claudication. J Vasc Surg 57 (2013), 720–727.e1.
Watson, C.J., Phillips, D., Hands, L., et al. Claudication distance is poorly estimated and inappropriately measured. Br J Surg 84 (1997), 1107–1109.
Le Faucheur, A., Abraham, P., Jaquinandi, V., et al. Measurement of walking distance and speed in patients with peripheral arterial disease: a novel method using a global positioning system. Circulation 117 (2008), 897–904.
Mahe, G., Ouedraogo, N., Marchand, J., et al. Self-reported estimation of usual walking speed improves the performance of questionnaires estimating walking capacity in patients with vascular-type claudication. J Vasc Surg 54 (2011), 1360–1365.
Ouedraogo, N., Mahe, G., Marchand, J., et al. Validation of a new simple questionnaire to “estimate ambulation capacity by history” (EACH) in patients with claudication. J Vasc Surg 54 (2011), 133–138.
Tew, G., Copeland, R., Le Faucheur, A., et al. Feasibility and validity of self-reported walking capacity in patients with intermittent claudication. J Vasc Surg 57 (2013), 1227–1234.
Nicolai, S.P., Viechtbauer, W., Kruidenier, L.M., et al. Reliability of treadmill testing in peripheral arterial disease: a meta-regression analysis. J Vasc Surg 50 (2009), 322–329.
Hiatt, W.R., Rogers, R.K., Brass, E.P., The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation 130 (2014), 69–78.
McDermott, M.M., Guralnik, J.M., Criqui, M.H., et al. Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease. Circulation 130 (2014), 61–68.
McDermott, M.M., Ades, P.A., Dyer, A., et al. Corridor-based functional performance measures correlate better with physical activity during daily life than treadmill measures in persons with peripheral arterial disease. J Vasc Surg 48 (2008), 1231–1237.
Le Faucheur, A., de Mullenheim, P.Y., Mahe, G., Letter by Le Faucheur et al regarding articles, “Six-minute walk is a better outcome measure than treadmill walking tests in therapeutic trials of patients with peripheral artery disease” and "The treadmill is a better functional test than the 6-minute walk test in therapeutic trials of patients with peripheral artery disease. Circulation, 131, 2015, e406.
Descotes, J., Cathignol, D., [Classification of changes in circulatory rate in the arteries of the lower limbs. Transcutaneous measurement by Doppler effect]. Nouv Presse Med 4 (1975), 2091–2093.
Becker, F., Luizy, F., Baud, J.M., et al. [Quality standards for ultrasound assessment (CW-Doppler, Duplex US) of the lower limb arteries in vascular medicine. Report of the French Society for Vascular Medicine]. J Mal Vasc 36 (2011), 364–385.
Polak, J.F., Karmel, M.I., Mannick, J.A., et al. Determination of the extent of lower-extremity peripheral arterial disease with color-assisted duplex sonography: comparison with angiography. AJR Am J Roentgenol 155 (1990), 1085–1089.
Becker, F., Écho-Doppler des artères des membres inférieurs. Les explorations vasculaires, 2014, Elsevier Masson SAS.
Gerhard-Herman, M., Gardin, J.M., Jaff, M., et al. Guidelines for noninvasive vascular laboratory testing: a report from the American society of Echocardiography and the society for vascular medicine and biology. Vasc Med 11 (2006), 183–200.
Ranke, C., Creutzig, A., Alexander, K., Duplex scanning of the peripheral arteries: correlation of the peak velocity ratio with angiographic diameter reduction. Ultrasound Med Biol 18 (1992), 433–440.
Jager, K.A., Phillips, D.J., Martin, R.L., et al. Noninvasive mapping of lower limb arterial lesions. Ultrasound Med Biol 11 (1985), 515–521.
Bura-Riviere, A., Mahé, G., Maladies artérielles. 2016, Elsevier Masson, Issy-les Moulineaux, France.
Bandyk, D.F., Johnson, B.L., Gupta, A.K., et al. Nature and management of duplex abnormalities encountered during infrainguinal vein bypass grafting. J Vasc Surg 24 (1996), 430–436 [discussion 7-8].
de Smet, A.A., Ermers, E.J., Kitslaar, P.J., Duplex velocity characteristics of aortoiliac stenoses. J Vasc Surg 23 (1996), 628–636.
Hodgkiss-Harlow, K.D., Bandyk, D.F., Interpretation of arterial duplex testing of lower-extremity arteries and interventions. Semin Vasc Surg 26 (2013), 95–104.
Khan, S.Z., Khan, M.A., Bradley, B., et al. Utility of duplex ultrasound in detecting and grading de novo femoropopliteal lesions. J Vasc Surg 54 (2011), 1067–1073.
Tinder, C.N., Bandyk, D.F., Detection of imminent vein graft occlusion: what is the optimal surveillance program?. Semin Vasc Surg 22 (2009), 252–260.
Baril, D.T., Marone, L.K., Duplex evaluation following femoropopliteal angioplasty and stenting: criteria and utility of surveillance. Vasc Endovascular Surg 46 (2012), 353–357.
Kristensen, S.D., Knuuti, J., Saraste, A., et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur Heart J 35 (2014), 2383–2431.
Eikelboom, J.W., Connolly, S.J., Bosch, J., et al. Rivaroxaban with or without aspirin in stable cardiovascular disease. N Engl J Med 377 (2017), 1319–1330.
Ponikowski, P., Voors, A.A., Anker, S.D., et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 37 (2016), 2129–2200.
Griffin, W.F., Salahuddin, T., O'Neal, W.T., et al. Peripheral arterial disease is associated with an increased risk of atrial fibrillation in the elderly. Europace 18 (2016), 794–798.
Winkel, T.A., Hoeks, S.E., Schouten, O., et al. Prognosis of atrial fibrillation in patients with symptomatic peripheral arterial disease: data from the REduction of Atherothrombosis for Continued Health (REACH) Registry. Eur J Vasc Endovasc Surg 40 (2010), 9–16.
Aboyans, V., Lacroix, P., Echahidi, N., et al. Ankle-brachial index in patients with nonvalvular atrial fibrillation. J Am Coll Cardiol 63 (2014), 1456–1457.
Gallego, P., Roldan, V., Marin, F., et al. Ankle brachial index as an independent predictor of mortality in anticoagulated atrial fibrillation. Eur J Clin Invest 42 (2012), 1302–1308.
Collet, J.P., Cayla, G., Ennezat, P.V., et al. Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: the randomized America Study. Int J Cardiol 254 (2018), 36–42.
Dencker, D., Pedersen, F., Engstrom, T., et al. Major femoral vascular access complications after coronary diagnostic and interventional procedures: a Danish register study. Int J Cardiol 202 (2016), 604–608.
Jones, W.S., Clare, R., Ellis, S.J., et al. Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION). Am J Cardiol 108 (2011), 380–384.
Nashef, S.A., Roques, F., Sharples, L.D., et al. EuroSCORE II. Eur J Cardiothorac Surg 41 (2012), 734–744 [discussion 44-45].
Antithrombotic Trialists, C., Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002), 71–86.
Berger, J.S., Krantz, M.J., Kittelson, J.M., et al. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials. JAMA 301 (2009), 1909–1919.
Committee, C.S., A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee. Lancet 348 (1996), 1329–1339.
Basili, S., Raparelli, V., Vestri, A., et al. Comparison of efficacy of antiplatelet treatments for patients with claudication. A meta-analysis. Thromb Haemost 103 (2010), 766–773.
Katsanos, K., Spiliopoulos, S., Saha, P., et al. Comparative efficacy and safety of different antiplatelet agents for prevention of major cardiovascular events and leg amputations in patients with peripheral arterial disease: a systematic review and network meta-analysis. PLoS One, 10, 2015, e0135692.
Belch, J., MacCuish, A., Campbell, I., et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ, 337, 2008, a1840.
Fowkes, F.G., Price, J.F., Stewart, M.C., et al. Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial. JAMA 303 (2010), 841–848.
Valgimigli, M., Bueno, H., Byrne, R.A., et al. 2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: the Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 39 (2018), 213–260.
Cacoub, P.P., Bhatt, D.L., Steg, P.G., et al. Patients with peripheral arterial disease in the CHARISMA trial. Eur Heart J 30 (2009), 192–201.
Dake, M.D., Ansel, G.M., Jaff, M.R., et al. Durable clinical effectiveness with paclitaxel-eluting stents in the femoropopliteal artery: 5-year results of the Zilver PTX randomized trial. Circulation 133 (2016), 1472–1483 [discussion 83].
Belch, J.J., Dormandy, J., Committee, C.W., et al. Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial. J Vasc Surg 52 (2010), 825–833.
Norgard, N.B., Mathews, K.D., Wall, G.C., Drug-drug interaction between clopidogrel and the proton pump inhibitors. Ann Pharmacother 43 (2009), 1266–1274.
Investigators, W., The effects of oral anticoagulants in patients with peripheral arterial disease: rationale, design, and baseline characteristics of the Warfarin and Antiplatelet Vascular Evaluation (WAVE) trial, including a meta-analysis of trials. Am Heart J 151 (2006), 1–9.
Warfarin Antiplatelet Vascular Evaluation Trial I Anand, S., Yusuf, S., Oral anticoagulant and antiplatelet therapy and peripheral arterial disease. N Engl J Med 357 (2007), 217–227.
Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial. Lancet 355 (2000), 346–351.
Anand, S.S., Bosch, J., Eikelboom, J.W., et al. Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial. Lancet 391 (2018), 219–229.
Anand, S.S., Caron, F., Eikelboom, J.W., et al. Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial. J Am Coll Cardiol 71 (2018), 2306–2315.
Anand, S.S., Eikelboom, J.W., Dyal, L., et al. Rivaroxaban plus aspirin versus aspirin in relation to vascular risk in the COMPASS trial. J Am Coll Cardiol 73 (2019), 3271–3280.
Bhatt, D.L.E., Connolly, S.J., et al. The Role of Combination Antiplatelet and Anticoagulation Therapy in Diabetes and Cardiovascular Disease: Insights from the COMPASS Trial Circulation. N Engl J Med 382 (2020), 1994–2004.
Bonaca, M.P., Bauersachs, R.M., Anand, S.S., et al. Rivaroxaban in peripheral artery disease after revascularization. N Engl J Med, 2020.
Mehran, R., Rao, S.V., Bhatt, D.L., et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation 123 (2011), 2736–2747.
Aboyans, V., Ricco, J.B., Bartelink, M.E.L., et al. 2017 ESC guidelines on the diagnosis and treatment of peripheral arterial diseases, in collaboration with the European society for vascular surgery (ESVS): document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteriesEndorsed by: the European stroke organization (ESO)the task force for the diagnosis and treatment of peripheral arterial diseases of the European society of Cardiology (ESC) and of the European society for vascular surgery (ESVS). Eur Heart J 39 (2018), 763–816.
Bhatt, D.L., Cryer, B.L., Contant, C.F., et al. Clopidogrel with or without omeprazole in coronary artery disease. N Engl J Med 363 (2010), 1909–1917.
Moayyedi, P., Eikelboom, J.W., Bosch, J., et al. Pantoprazole to prevent gastroduodenal events in patients receiving rivaroxaban and/or aspirin in a randomized, double-blind, placebo-controlled trial. Gastroenterology 157 (2019), 403–412.e5.
Furuta, T., Iwaki, T., Umemura, K., Influences of different proton pump inhibitors on the anti-platelet function of clopidogrel in relation to CYP2C19 genotypes. Br J Clin Pharmacol 70 (2010), 383–392.
Grundy, S.M., Stone, N.J., Bailey, A.L., et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American heart association task force on clinical practice guidelines. J Am Coll Cardiol 73 (2019), e285–e350.
Bonaca, M.P., Nault, P., Giugliano, R.P., et al. Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (further cardiovascular outcomes research with PCSK9 inhibition in subjects with elevated risk). Circulation 137 (2018), 338–350.
Sabatine, M.S., Giugliano, R.P., Keech, A.C., et al. Evolocumab and clinical outcomes in patients with cardiovascular disease. N Engl J Med 376 (2017), 1713–1722.
Wang, D., Liu, B., Tao, W., et al. Fibrates for secondary prevention of cardiovascular disease and stroke. Cochrane Database Syst Rev, 10, 2015, CD009580.
Bhatt, D.L., Steg, P.G., Miller, M., et al. Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia. N Engl J Med 380 (2019), 11–22.
Williams, B., Mancia, G., Spiering, W., et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. Eur Heart J 39 (2018), 3021–3104.
Heart Outcomes Prevention Evaluation Study, I., Yusuf, S., Sleight, P., et al. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 (2000), 145–153.
Investigators, O., Yusuf, S., Teo, K.K., et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med 358 (2008), 1547–1559.
Ueda, P., Svanstrom, H., Melbye, M., et al. Sodium glucose cotransporter 2 inhibitors and risk of serious adverse events: nationwide register based cohort study. BMJ, 363, 2018, k4365.
Davis, M.M., Taubert, K., Benin, A.L., et al. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. Circulation 114 (2006), 1549–1553.
Ciszewski, A., Bilinska, Z.T., Brydak, L.B., et al. Influenza vaccination in secondary prevention from coronary ischaemic events in coronary artery disease: FLUCAD study. Eur Heart J 29 (2008), 1350–1358.
Gurfinkel, E.P., Leon de la Fuente, R., Mendiz, O., et al. Flu vaccination in acute coronary syndromes and planned percutaneous coronary interventions (FLUVACS) Study. Eur Heart J 25 (2004), 25–31.
INSERM. Activité physique – Prévention et traitement des maladies chroniques. 2019, Éditions EDP Sciences. Collection Expertise collective. Montrouge: EDP Sciences, 2019, XVI-805 p http://hdl.handle.net/10608/9690.
Gardner, A.W., Montgomery, P.S., Flinn, W.R., et al. The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication. J Vasc Surg 42 (2005), 702–709.
Villemur, B., Marquer, A., Gailledrat, E., et al. New rehabilitation program for intermittent claudication: interval training with active recovery: pilot study. Ann Phys Rehabil Med 54 (2011), 275–281.
Vun, S.V., Miller, M.D., Delaney, C.L., et al. The effect of supervised exercise therapy for intermittent claudication on lower limb lean mass. J Vasc Surg 64 (2016), 1763–1769.
Gardner, A.W., Poehlman, E.T., Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis. JAMA 274 (1995), 975–980.
Hiatt, W.R., Wolfel, E.E., Meier, R.H., et al. Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response. Circulation 90 (1994), 1866–1874.
Gardner, A.W., Parker, D.E., Montgomery, P.S., et al. Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial. Circulation 123 (2011), 491–498.
Fakhry, F., van de Luijtgaarden, K.M., Bax, L., et al. Supervised walking therapy in patients with intermittent claudication. J Vasc Surg 56 (2012), 1132–1142.
Gardner, A.W., Parker, D.E., Montgomery, P.S., et al. Step-monitored home exercise improves ambulation, vascular function, and inflammation in symptomatic patients with peripheral artery disease: a randomized controlled trial. J Am Heart Assoc, 3, 2014, e001107.
Murphy, T.P., Cutlip, D.E., Regensteiner, J.G., et al. Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study. Circulation 125 (2012), 130–139.
Lane, R., Ellis, B., Watson, L., et al. Exercise for intermittent claudication. Cochrane Database Syst Rev, 7, 2014, CD000990.
Stewart, K.J., Hiatt, W.R., Regensteiner, J.G., et al. Exercise training for claudication. N Engl J Med 347 (2002), 1941–1951.
Bronas, U.G., Treat-Jacobson, D., Leon, A.S., Comparison of the effect of upper body-ergometry aerobic training vs treadmill training on central cardiorespiratory improvement and walking distance in patients with claudication. J Vasc Surg 53 (2011), 1557–1564.
Tew, G., Nawaz, S., Zwierska, I., et al. Limb-specific and cross-transfer effects of arm-crank exercise training in patients with symptomatic peripheral arterial disease. Clin Sci (Lond) 117 (2009), 405–413.
Zwierska, I., Walker, R.D., Choksy, S.A., et al. Upper- vs lower-limb aerobic exercise rehabilitation in patients with symptomatic peripheral arterial disease: a randomized controlled trial. J Vasc Surg 42 (2005), 1122–1130.
McDermott, M.M., Liu, K., Guralnik, J.M., et al. Home-based walking exercise intervention in peripheral artery disease: a randomized clinical trial. JAMA 310 (2013), 57–65.
McDermott, M.M., Ades, P., Guralnik, J.M., et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 301 (2009), 165–174.
McDermott, M.M., Exercise rehabilitation for peripheral artery disease: a review. J Cardiopulm Rehabil Prev 38 (2018), 63–69.
Gommans, L.N., Fokkenrood, H.J., van Dalen, H.C., et al. Safety of supervised exercise therapy in patients with intermittent claudication. J Vasc Surg 61 (2015), 512–518.e2.
Myers, S.A., Johanning, J.M., Stergiou, N., et al. Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease. J Vasc Surg 47 (2008), 550–555.
Mays, R.J., Casserly, I.P., Kohrt, W.M., et al. Assessment of functional status and quality of life in claudication. J Vasc Surg 53 (2011), 1410–1421.
Treat-Jacobson, D., McDermott, M.M., Bronas, U.G., et al. Optimal exercise programs for patients with peripheral artery disease: a scientific statement from the American heart association. Circulation 139 (2019), e10–e33.
Murphy, T.P., Hirsch, A.T., Ricotta, J.J., et al. The Claudication: exercise Vs. Endoluminal Revascularization (CLEVER) study: rationale and methods. J Vasc Surg 47 (2008), 1356–1363.
Conte, M.S., Pomposelli, F.B., Society for Vascular Surgery Practice guidelines for atherosclerotic occlusive disease of the lower extremities management of asymptomatic disease and claudication. Introduction. J Vasc Surg, 61(3 Suppl), 2015, 1S.
Ricco, J.B., Probst, H., French University Surgeons A. Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease. J Vasc Surg 47 (2008), 45–53 [discussion -4].
AbuRahma, A.F., Robinson, P.A., Holt, S.M., Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses. Surgery 126 (1999), 594–601 [discussion -2].
Veith, F.J., Gupta, S.K., Ascer, E., et al. Six-year prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986), 104–114.
Schweiger, H., Klein, P., Lang, W., Tibial bypass grafting for limb salvage with ringed polytetrafluoroethylene prostheses: results of primary and secondary procedures. J Vasc Surg 18 (1993), 867–874.
Karkos, C.D., Wood, A., Bruce, I.A., et al. Erectile dysfunction after open versus angioplasty aortoiliac procedures: a questionnaire survey. Vasc Endovascular Surg 38 (2004), 157–165.
Rayt, H.S., Bown, M.J., Lambert, K.V., et al. Buttock claudication and erectile dysfunction after internal iliac artery embolization in patients prior to endovascular aortic aneurysm repair. Cardiovasc Intervent Radiol 31 (2008), 728–734.
Jacquinandi VB, P., Picquet, J., Leftheriotis, G., et al. Pain description in patients with isolated proximal (without distal) exercise-related lower limb arterial ischemia. Vasc Med 9 (2004), 261–265.
Katz JNH, M.B., Clinical practice. Lumbar spinal stenosis. N Engl J Med 358 (2008), 818–825.
Jaquinandi, V., Abraham, P., Picquet, J., et al. Estimation of the functional role of arterial pathways to the buttock circulation during treadmill walking in patients with claudication. J Appl Physiol (1985) 102 (2007), 1105–1112.
Jaquinandi VP, J., Saumet, J.L., Benharash, P., et al. Functional assessment at the buttock level of the effect of aortobifemoral bypass surgery. Ann Surg 247 (2008), 869–876.
Mahe GL, G., Picquet, J., Jaquinandi, V., et al. A normal penile pressure cannot rule out the presence of lesions on the arteries supplying the hypogastric circulation in patients with arterial claudication. Vasc Med 14 (2009), 331–338.
Bruninx GS, H., Wery, D., Delcour, C., [Doppler study of gluteal arteries. A useful tool for excluding gluteal arterial pathology snd an important adjunct to lower limb Doppler studies]. J Mal Vasc 27 (2002), 12–17.
Picquet, J., Jaquinandi, V., Saumet, J.L., et al. Systematic diagnostic approach to proximal-without-distal claudication in a vascular population. Eur J Intern Med 16 (2005), 575–579.
Jaquinandi, V., Picquet, J., Bouye, P., et al. High prevalence of proximal claudication among patients with patent aortobifemoral bypasses. J Vasc Surg 45 (2007), 312–318.
Bouye, P., Jacquinandi, V., Picquet, J., et al. Near-infrared spectroscopy and transcutaneous oxygen pressure during exercise to detect arterial ischemia at the buttock level: comparison with arteriography. J Vasc Surg 41 (2005), 994–999.
Sugano, N., Inoue, Y., Iwai, T., Evaluation of buttock claudication with hypogastric artery stump pressure measurement and near infrared spectroscopy after abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 26 (2003), 45–51.
Comerota, A.J., Throm, R.C., Kelly, P., et al. Tissue (muscle) oxygen saturation (StO2): a new measure of symptomatic lower-extremity arterial disease. J Vasc Surg 38 (2003), 724–729.
Ubbink, D.T., Koopman, B., Near-infrared spectroscopy in the routine diagnostic work-up of patients with leg ischemia. Eur J Vasc Endovasc Surg 31 (2006), 394–400.
Segall, G.M., Lang, E.V., Lennon, S.E., et al. Functional imaging of peripheral vascular disease: a comparison between exercise whole-body thallium perfusion imaging and contrast arteriography. J Nucl Med 33 (1992), 1797–1800.
Donas, K.P., Schwindt, A., Pitoulias, G.A., et al. Endovascular treatment of internal iliac artery obstructive disease. J Vasc Surg 49 (2009), 1447–1451.
Thompson, K., Cook, P., Dilley, R., et al. Internal iliac artery angioplasty and stenting: an underutilized therapy. Ann Vasc Surg 24 (2010), 23–27.
Picquet, J., Miot, S., Abraham, P., et al. Crossed retroperitoneal approach to the internal iliac artery: a preliminary anatomical study. Surg Radiol Anat 28 (2006), 180–184.
Tetteroo, E., van der Graaf, Y., Bosch, J.L., et al. Randomised comparison of primary stent placement versus primary angioplasty followed by selective stent placement in patients with iliac-artery occlusive disease. Dutch Iliac Stent Trial Study Group. Lancet 351 (1998), 1153–1159.
Prince, J.F., Smits, M.L., van Herwaarden, J.A., et al. Endovascular treatment of internal iliac artery stenosis in patients with buttock claudication. PLoS One, 8, 2013, e73331.
Morse, S.S., Cambria, R., Strauss, E.B., et al. Transluminal angioplasty of the hypogastric artery for treatment of buttock claudication. Cardiovasc Intervent Radiol 9 (1986), 136–138.
Smith, G., Train, J., Mitty, H., et al. Hip pain caused by buttock claudication. Relief of symptoms by transluminal angioplasty. Clin Orthop Relat Res 284 (1992), 176–180.
Adlakha, S., Burket, M., Cooper, C., Percutaneous intervention for chronic total occlusion of the internal iliac artery for unrelenting buttock claudication. Catheter Cardiovasc Interv 74 (2009), 257–259.
Huetink, K., Steijling, J.J., Mali, W.P., Endovascular treatment of the internal iliac artery in peripheral arterial disease. Cardiovasc Intervent Radiol 31 (2008), 391–393.
Batt, M., Baque, J., Ajmia, F., et al. Angioplasty of the superior gluteal artery in 34 patients with buttock claudication. J Endovasc Ther 21 (2014), 400–406.
Batt, M., Baque, J., Bouillanne, P.J., et al. Percutaneous angioplasty of the superior gluteal artery for buttock claudication: a report of seven cases and literature review. J Vasc Surg 43 (2006), 987–991.
Paumier, A., Abraham, P., Mahe, G., et al. Functional outcome of hypogastric revascularisation for prevention of buttock claudication in patients with peripheral artery occlusive disease. Eur J Vasc Endovasc Surg 39 (2010), 323–329.
Maugin, E., Abraham, P., Paumier, A., et al. Patency of direct revascularisation of the hypogastric arteries in patients with aortoiliac occlusive disease. Eur J Vasc Endovasc Surg 42 (2011), 78–82.
Mansour, W., Capoccia, L., Sirignano, P., et al. Clinical and functional impact of hypogastric artery exclusion during EVAR. Vasc Endovascular Surg 50 (2016), 484–490.
Chiu, R.C., Lidstone, D., Blundell, P.E., Predictive power of penile/brachial index in diagnosing male sexual impotence. J Vasc Surg 4 (1986), 251–256.
Bekken, J., Jongsma, H., Ayez, N., et al. Angioplasty versus stenting for iliac artery lesions. Cochrane Database Syst Rev, 5, 2015, CD007561.
White, C., Clinical practice. Intermittent claudication. N Engl J Med 356 (2007), 1241–1250.
Sigvant, B., Lundin, F., Wahlberg, E., The risk of disease progression in peripheral arterial disease is higher than expected: a meta-analysis of mortality and disease progression in peripheral arterial disease. Eur J Vasc Endovasc Surg 51 (2016), 395–403.
Abu Dabrh, A.M., Steffen, M.W., Undavalli, C., et al. The natural history of untreated severe or critical limb ischemia. J Vasc Surg 62 (2015), 1642–1651.e3.
Bell PRC, D., DePalma, R.G., The definition of critical ischemia of a limb. Working Party of the International Vascular Symposium. Br J Surg, 69, 1982, S2.
Second European Consensus Document on chronic critical leg ischemia. Eur J Vasc Surg 6:Suppl A (1992), 1–32.
European consensus on critical limb ischemia. Lancet 333 (1989), 737–738.
Rutherford, R.B., Baker, J.D., Ernst, C., et al. Recommended standards for reports dealing with lower extremity ischemia: revised version. J Vasc Surg 26 (1997), 517–538.
Vircoulon, M., Boulon, C., Desormais, I., et al. Comparison of one-year prognosis of patients classified as chronic critical lower limb ischemia according to TASC II or European consensus definition in the COPART cohort. Vasa 44 (2015), 220–228.
Salaun, P., Desormais, I., Lapebie, F.X., et al. Comparison of ankle pressure, systolic toe pressure, and transcutaneous oxygen pressure to predict major amputation after 1 Year in the COPART cohort. Angiology, 2018 3319718793566.
Second European Consensus Document on chronic critical leg ischemia. Circulation 84:4 Suppl (1991), IV1–26.
Miller, J.D., Carter, E., Shih, J., et al. How to do a 3-minute diabetic foot exam. J Fam Pract 63 (2014), 646–656.
Mills, J.L. Sr., Conte, M.S., Armstrong, D.G., et al. The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg 59 (2014), 220–234.
Pickwell, K., Siersma, V., Kars, M., et al. Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer. Diabetes Care 38 (2015), 852–857.
Prompers, L., Schaper, N., Apelqvist, J., et al. Prediction of outcome in individuals with diabetic foot ulcers: focus on the differences between individuals with and without peripheral arterial disease. The EURODIALE Study. Diabetologia 51 (2008), 747–755.
Driver, V.R., Madsen, J., Goodman, R.A., Reducing amputation rates in patients with diabetes at a military medical center: the limb preservation service model. Diabetes Care 28 (2005), 248–253.
Vartanian, S.M., Robinson, K.D., Ofili, K., et al. Outcomes of neuroischemic wounds treated by a multidisciplinary amputation prevention service. Ann Vasc Surg 29 (2015), 534–542.
Williams, D.T., Majeed, M.U., Shingler, G., et al. A diabetic foot service established by a department of vascular surgery: an observational study. Ann Vasc Surg 26 (2012), 700–706.
Wagner, F.W. Jr., The diabetic foot. Orthopedics 10 (1987), 163–172.
Conte, M.S., Bradbury, A.W., Kolh, P., et al. Global vascular guidelines on the management of chronic limb-threatening ischemia. Eur J Vasc Endovasc Surg 58 (2019), S1–S109.e33.
Beropoulis, E., Stavroulakis, K., Schwindt, A., et al. Validation of the Wound, Ischemia, foot Infection (WIfI) classification system in nondiabetic patients treated by endovascular means for critical limb ischemia. J Vasc Surg 64 (2016), 95–103.
Causey, M.W., Ahmed, A., Wu, B., et al. Society for Vascular Surgery limb stage and patient risk correlate with outcomes in an amputation prevention program. J Vasc Surg 63 (2016), 1563–1573.e2.
Darling, J.D., McCallum, J.C., Soden, P.A., et al. Predictive ability of the Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system following infrapopliteal endovascular interventions for critical limb ischemia. J Vasc Surg 64 (2016), 616–622.
Zhan, L.X., Branco, B.C., Armstrong, D.G., et al. The Society for Vascular Surgery lower extremity threatened limb classification system based on Wound, Ischemia, and foot Infection (WIfI) correlates with risk of major amputation and time to wound healing. J Vasc Surg 61 (2015), 939–944.
van Reijen, N.S., Ponchant, K., Ubbink, D.T., et al. The prognostic value of the WIfI classification in patients with chronic limb threatening ischemia: a systematic review and meta-analysis. Eur J Vasc Endovasc Surg, 2019.
Robinson, W.P., Loretz, L., Hanesian, C., et al. Society for Vascular Surgery Wound, Ischemia, foot Infection (WIfI) score correlates with the intensity of multimodal limb treatment and patient-centered outcomes in patients with threatened limbs managed in a limb preservation center. J Vasc Surg 66 (2017), 488–498.e2.
Mathioudakis, N., Hicks, C.W., Canner, J.K., et al. The Society for Vascular Surgery Wound, Ischemia, and foot Infection (WIfI) classification system predicts wound healing but not major amputation in patients with diabetic foot ulcers treated in a multidisciplinary setting. J Vasc Surg 65 (2017), 1698–1705.e1.
Larsson, J., Apelqvist, J., Agardh, C.D., et al. Decreasing incidence of major amputation in diabetic patients: a consequence of a multidisciplinary foot care team approach?. Diabet Med 12 (1995), 770–776.
Armstrong, D.G., Bharara, M., White, M., et al. The impact and outcomes of establishing an integrated interdisciplinary surgical team to care for the diabetic foot. Diabetes Metab Res Rev 28 (2012), 514–518.
Adam, D.J., Beard, J.D., Cleveland, T., et al. Bypass versus angioplasty in severe ischemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet 366 (2005), 1925–1934.
Bradbury, A.W., Adam, D.J., Bell, J., et al. Multicentre randomised controlled trial of the clinical and cost-effectiveness of a bypass-surgery-first versus a balloon-angioplasty-first revascularisation strategy for severe limb ischemia due to infrainguinal disease. The Bypass versus Angioplasty in Severe Ischemia of the Leg (BASIL) trial. Health Technol Assess 14 (2010), 1–210.
Kodama, A.M.L., Popplewell, M., Bate, G., et al. Validation of the global anatomic staging system (GLASS) using the BASIL-1 best endovascular therapy cohort. Eur J Vasc Endovasc Surg, 56, 2018, e27.
Krankenberg, H., Schluter, M., Steinkamp, H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116 (2007), 285–292.
Schillinger, M., Sabeti, S., Dick, P., et al. Sustained benefit at 2 years of primary femoropopliteal stenting compared with balloon angioplasty with optional stenting. Circulation 115 (2007), 2745–2749.
Bosanquet, D.C., Glasbey, J.C., Williams, I.M., et al. Systematic review and meta-analysis of direct versus indirect angiosomal revascularisation of infrapopliteal arteries. Eur J Vasc Endovasc Surg 48 (2014), 88–97.
Taylor, G.I., Palmer, J.H., The vascular territories (angiosomes) of the body: experimental study and clinical applications. Br J Plast Surg 40 (1987), 113–141.
Attinger, C.E., Evans, K.K., Bulan, E., et al. Angiosomes of the foot and ankle and clinical implications for limb salvage: reconstruction, incisions, and revascularization. Plast Reconstr Surg 117:7 Suppl (2006), 261S–293S.
Alexandrescu, V., Soderstrom, M., Venermo, M., Angiosome theory: fact or fiction?. Scand J Surg 101 (2012), 125–131.
Huang, T.Y., Huang, T.S., Wang, Y.C., et al. Direct revascularization with the angiosome concept for lower limb ischemia: a systematic review and meta-analysis. Medicine (Baltimore), 94, 2015, e1427.
Chae, K.J., Shin, J.Y., Is angiosome-targeted angioplasty effective for limb salvage and wound healing in diabetic foot?: a meta-analysis. PLoS One, 11, 2016, e0159523.
Kobayashi, N., Hirano, K., Nakano, M., et al. Prognosis of critical limb ischemia patients with tissue loss after achievement of complete wound healing by endovascular therapy. J Vasc Surg 61 (2015), 951–959.
Chung, J., Modrall, J.G., Ahn, C., et al. Multidisciplinary care improves amputation-free survival in patients with chronic critical limb ischemia. J Vasc Surg 61 (2015), 162–169.
Van Gils, C.C., Wheeler, L.A., Mellstrom, M., et al. Amputation prevention by vascular surgery and podiatry collaboration in high-risk diabetic and nondiabetic patients. The Operation Desert Foot experience. Diabetes Care 22 (1999), 678–683.
Johnson, W.C., Lee, K.K., A comparative evaluation of polytetrafluoroethylene, umbilical vein, and saphenous vein bypass grafts for femoral-popliteal above-knee revascularization: a prospective randomized Department of Veterans Affairs cooperative study. J Vasc Surg 32 (2000), 268–277.
Nolan, B.W., De Martino, R.R., Stone, D.H., et al. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg 54 (2011), 730–735 [discussion 5-6].
Santo, V.J., Dargon, P., Azarbal, A.F., et al. Lower extremity autologous vein bypass for critical limb ischemia is not adversely affected by prior endovascular procedure. J Vasc Surg 60 (2014), 129–135.
Uhl, C., Hock, C., Betz, T., et al. Pedal bypass surgery after crural endovascular intervention. J Vasc Surg 59 (2014), 1583–1587.
Abidia, A., Laden, G., Kuhan, G., et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomised-controlled trial. Eur J Vasc Endovasc Surg 25 (2003), 513–518.
Santema, K.T.B., Stoekenbroek, R.M., Koelemay, M.J.W., et al. Hyperbaric oxygen therapy in the treatment of ischemic lower- extremity ulcers in patients with diabetes: results of the DAMO2CLES multicenter randomized clinical trial. Diabetes Care 41 (2018), 112–119.
Kranke, P., Bennett, M.H., Martyn-St James, M., et al. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev, 2015, CD004123.
Ruffolo, A.J., Romano, M., Ciapponi, A., Prostanoids for critical limb ischemia. Cochrane Database Syst Rev, 1, 2010, CD006544.
Vietto, V., Franco, J.V., Saenz, V., et al. Prostanoids for critical limb ischemia. Cochrane Database Syst Rev, 1, 2018, CD006544.
Smith, F.B., Bradbury, A., Fowkes, G., Intravenous naftidrofuryl for critical limb ischemia. Cochrane Database Syst Rev, 2012, CD002070.
Moran, P.S., Teljeur, C., Harrington, P., et al. A systematic review of intermittent pneumatic compression for critical limb ischemia. Vasc Med 20 (2015), 41–50.
Armstrong, E.J., Chen, D.C., Westin, G.G., et al. Adherence to guideline-recommended therapy is associated with decreased major adverse cardiovascular events and major adverse limb events among patients with peripheral arterial disease. J Am Heart Assoc, 3, 2014, e000697.
Hobaus, C., Herz, C.T., Obendorf, F., et al. Center-based patient care enhances survival of elderly patients suffering from peripheral arterial disease. Ann Med 49 (2017), 291–298.
Hussain, M.A., Al-Omran, M., Mamdani, M., et al. Efficacy of a guideline-recommended risk-reduction program to improve cardiovascular and limb outcomes in patients with peripheral arterial disease. JAMA Surg 151 (2016), 742–750.
Venermo, M., Sprynger, M., Desormais, I., et al. Editor's choice - follow-up of patients after revascularisation for peripheral arterial diseases: a consensus document from the European society of Cardiology working group on aorta and peripheral vascular diseases and the European society for vascular surgery. Eur J Vasc Endovasc Surg 58 (2019), 641–653.
Lane, T.R., Metcalfe, M.J., Narayanan, S., et al. Post-operative surveillance after open peripheral arterial surgery. Eur J Vasc Endovasc Surg 42 (2011), 59–77.
Bandyk, D.F., Seabrook, G.R., Moldenhauer, P., et al. Hemodynamics of vein graft stenosis. J Vasc Surg 8 (1988), 688–695.
Mc, B.O., Chalmers, R.T., Follow-up and surveillance of vein grafts: when and how to intervene to prevent complications. J Cardiovasc Surg (Torino) 58 (2017), 284–292.
Abu Dabrh, A.M., Mohammed, K., Farah, W., et al. Systematic review and meta-analysis of duplex ultrasound surveillance for infrainguinal vein bypass grafts. J Vasc Surg 66 (2017), 1885–18891 e8.
Lundell, A., Lindblad, B., Bergqvist, D., et al. Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study. J Vasc Surg 21 (1995), 26–33 [discussion -4].
McBride, O.M.B., Mofidi, R., Griffiths, G.D., et al. Development of a decision tree to streamline infrainguinal vein graft surveillance. Ann Vasc Surg 36 (2016), 182–189.
Lawall, H., Huppert, P., Espinola-Klein, C., et al. German guideline on the diagnosis and treatment of peripheral artery disease - a comprehensive update 2016. Vasa 46 (2017), 79–86.
Ambler, G.K., Twine, C.P., Graft type for femoro-popliteal bypass surgery. Cochrane Database Syst Rev, 2, 2018, CD001487.
Zierler, R.E., Jordan, W.D., Lal, B.K., et al. The Society for Vascular Surgery practice guidelines on follow-up after vascular surgery arterial procedures. J Vasc Surg 68 (2018), 256–284.
American College of Cardiology F, American College of R, American Institute of Ultrasound in M, American Society of E, American Society of N, Intersocietal Commission for the Accreditation of Vascular L. ACCF/ACR/AIUM/ASE/ASN/ICAVL/SCAI/SCCT/SIR/SVM/SVS 2012 appropriate use criteria for peripheral vascular ultrasound and physiological testing part I: arterial ultrasound and physiological testing: a report of the American College of Cardiology foundation appropriate use criteria task force, American College of radiology, American institute of ultrasound in medicine, American society of Echocardiography, American society of nephrology, intersocietal commission for the accreditation of vascular laboratories, society for cardiovascular angiography and interventions, society of cardiovascular computed tomography, society for interventional radiology, society for vascular medicine, and society for vascular surgery. J Vasc Surg 56 (2012), e17–51.
Brostow, D.P., Hirsch, A.T., Collins, T.C., et al. The role of nutrition and body composition in peripheral arterial disease. Nat Rev Cardiol 9 (2012), 634–643.
Iqbal, R., Anand, S., Ounpuu, S., et al. Dietary patterns and the risk of acute myocardial infarction in 52 countries: results of the INTERHEART study. Circulation 118 (2008), 1929–1937.
Lane, J.S., Magno, C.P., Lane, K.T., et al. Nutrition impacts the prevalence of peripheral arterial disease in the United States. J Vasc Surg 48 (2008), 897–904.
Lopez-Laguna, N., Martinez-Gonzalez, M.A., Toledo, E., et al. Risk of peripheral artery disease according to a healthy lifestyle score: the PREDIMED study. Atherosclerosis 275 (2018), 133–140.
Carsin, M., Mahe, G., [Why should vascular patients have a dietary assessment?]. J Mal Vasc 35 (2010), 17–22.
Carsin-Mahe, M., Abraham, P., Le Faucheur, A., et al. Simple routine assessment of dietary pattern in patients with peripheral artery disease. J Vasc Surg 56 (2012), 281–282.
Gardner, A.W., Bright, B.C., Ort, K.A., et al. Dietary intake of participants with peripheral artery disease and claudication. Angiology 62 (2011), 270–275.
Nosova, E.V., Bartel, K., Chong, K.C., et al. Analysis of nutritional habits and intake of polyunsaturated fatty acids in veterans with peripheral arterial disease. Vasc Med 20 (2015), 432–438.
de Lorgeril, M., Salen, P., Martin, J.L., et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation 99 (1999), 779–785.
Iestra, J., Knoops, K., Kromhout, D., et al. Lifestyle, Mediterranean diet and survival in European post-myocardial infarction patients. Eur J Cardiovasc Prev Rehabil 13 (2006), 894–900.
Grenon, S.M., Owens, C.D., Nosova, E.V., et al. Short-term, high-dose fish oil supplementation increases the production of omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the OMEGA-PAD I trial). J Am Heart Assoc, 4, 2015, e002034.
Delaney, C.L., Miller, M.D., Dickinson, K.M., et al. Change in dietary intake of adults with intermittent claudication undergoing a supervised exercise program and compared to matched controls. Nutr J, 13, 2014, 100.
Salomon du Mont, L., Leclerc, B., Morgant, M.C., et al. Impact of nutritional state on critical limb ischemia early outcomes (DENUCRITICC study). Ann Vasc Surg 45 (2017), 10–15.
Yokoyama, M., Watanabe, T., Otaki, Y., et al. Impact of objective malnutrition status on the clinical outcomes in patients with peripheral artery disease following endovascular therapy. Circ J 82 (2018), 847–856.
Durkin, M.T., Mercer, K.G., McNulty, M.F., et al. Vascular surgical society of great britain and Ireland: contribution of malnutrition to postoperative morbidity in vascular surgical patients. Br J Surg, 86, 1999, 702.
Gau, B.R., Chen, H.Y., Hung, S.Y., et al. Erratum to "The impact of nutritional status on treatment outcomes of patients with limb-threatening diabetic foot ulcers". J Diabet Complications, 30, 2016, 971.
Gau, B.R., Chen, H.Y., Hung, S.Y., et al. The impact of nutritional status on treatment outcomes of patients with limb-threatening diabetic foot ulcers. J Diabet Complications 30 (2016), 138–142.
Thomas, J., Kaambwa, B., Delaney, C., et al. An evaluation of the validity of nutrition screening and assessment tools in patients admitted to a vascular surgery unit. Br J Nutr, 2019, 1–26.
Delaney, C.L., Smale, M.K., Miller, M.D., Nutritional considerations for peripheral arterial disease: a narrative review. Nutrients, 11, 2019.
Thomas, J., Delaney, C., Suen, J., et al. Nutritional status of patients admitted to a metropolitan tertiary care vascular surgery unit. Asia Pac J Clin Nutr 28 (2019), 64–71.
